Alps Group Inc (ALPS)
Alps Group Inc operates in the Biotechnology industry of the Healthcare sector, headquartered in Kuala Lumpur, WP, MY. The stock last traded at $0.40, down 1.00% on the session, giving a market capitalisation of $65.9M. On trailing twelve-month figures it carries a trailing P/E of -0.43, a net margin of 0.0%. Its beta of -0.06 implies it has historically moved less than the broad market.
Alps Group Inc. operates as a comprehensive biotechnology firm, delivering a wide array of services ranging from groundbreaking research and development to direct medical care and health optimization initiatives, with a primary focus on cutting-edge therapeutic solutions. The organization is committed to cultivating a just and balanced healthcare system, ensuring broad availability of early detection, disease prevention, and individualized treatment approaches.
Alps Group Inc is most often compared with the following Healthcare names: